Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Notch signal strength controls cell fate in the haemogenic endothelium.

  • Gama-Norton, Leonor
  • Ferrando Martorell, Eva, 1986-
  • Ruiz Herguido, Cristina
  • Liu, Zenhy
  • Guiu Sagarra, Jordi, 1983-
  • Islam, Abul, 1978-
  • Lee, Sung-Uk
  • Yan, Minhong
  • Guidos, Cynthia J.
  • López Bigas, Núria
  • Maeda, Takahiro
  • Espinosa Blay, Lluís
  • Kopan, Raphael
  • Bigas Salvans, Anna
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-mesonephros (AGM) region prior to haematopoietic stem cell (HSC) generation. The arterial programme depends on Dll4 and the haemogenic endothelium/HSC on Jag1-mediated Notch1 signalling. How Notch1 distinguishes and executes these different programmes in response to particular ligands is poorly understood. By using two Notch1 activation trap mouse models with different sensitivity, here we show that arterial endothelial cells and HSCs originate from distinct precursors, characterized by different Notch1 signal strengths. Microarray analysis on AGM subpopulations demonstrates that the Jag1 ligand stimulates low Notch strength, inhibits the endothelial programme and is permissive for HSC specification. In the absence of Jag1, endothelial cells experience high Dll4-induced Notch activity and select the endothelial programme, thus precluding HSC formation. Interference with the Dll4 signal by ligand-specific blocking antibodies is sufficient to inhibit the endothelial programme and favour specification of the haematopoietic lineage., L.G.-N. was a recipient of Marie Curie Intra-European Fellowship (PIEF-GA-2011- 302226). E.F. and J.G. are recipients of FPI (BES-2011-048360 and BES-2008-005708, respectively). This research was funded by the Ministerio de Economıa y Competitividad (PLE2009-0111, SAF2010-15450, SAF2013-40922-R), Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD12/0036/0054), Age`ncia de Gestio d’Ajuds Universitaris i de Recerca (AGAUR; 2014SGR-124) to A.B.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Lamin B1 mapping reveals the existence of dynamic and functional euchromatin lamin B1 domains

  • Pascual-Reguant, Laura, 1990-
  • Blanco, Enrique
  • Galan Martínez, Silvia, 1992-
  • Le Dily, François
  • Cuartero, Yasmina
  • Serra Bardenys, Gemma, 1992-
  • Di Carlo, Valerio
  • Iturbide Martínez de Albéniz, Ane, 1989-
  • Cebrià i Costa, Joan Pau, 1989-
  • Nonell Mazelon, Lara, 1972-
  • García de Herreros, Antonio
  • Di Croce, Luciano
  • Martí Renom, Marc A.
  • Peiró Sales, Sandra
Lamins (A/C and B) are major constituents of the nuclear lamina (NL). Structurally conserved lamina-associated domains (LADs) are formed by genomic regions that contact the NL. Lamins are also found in the nucleoplasm, with a yet unknown function. Here we map the genome-wide localization of lamin B1 in an euchromatin-enriched fraction of the mouse genome and follow its dynamics during the epithelial-to-mesenchymal transition (EMT). Lamin B1 associates with actively expressed and open euchromatin regions, forming dynamic euchromatin lamin B1-associated domains (eLADs) of about 0.3 Mb. Hi-C data link eLADs to the 3D organization of the mouse genome during EMT and correlate lamin B1 enrichment at topologically associating domain (TAD) borders with increased border strength. Having reduced levels of lamin B1 alters the EMT transcriptional signature and compromises the acquisition of mesenchymal traits. Thus, during EMT, the process of genome reorganization in mouse involves dynamic changes in eLADs, This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI15/00396; CPII14/0006), Ministerio de Economía y Competitividad (MINECO) (SAF2013-40922-R1; FPU14/0407; BFU2016-75008-P), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional-FEDER (SAF2016-76461-R), Generalitat de Catalunya (2014 SGR 32), Fundació FERO, Fundació La Marató TV3, and La Caixa Foundation. We also thank the Advanced Light Microscopy Unit at the CRG for their assistance and the Cellex Foundation for providing research facilities and equipment. M.A.M.-R. acknowledges funding from the European Research Council under the 7th Framework Program (FP7/2010-2015, ERC grant agreement 609989), the European Union’s Horizon 2020 research and innovation program (agreement 676556), the Spanish Ministry of Economy and Competitiveness (BFU2013-47736-P), and the Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208) to the CRG
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia

  • Robles-Valero, Javier
  • Lorenzo-Martín, L. Francisco
  • Menacho Márquez, Mauricio
  • Fernández-Pisonero, Isabel
  • Abad, Antonio
  • Camós, Mireia
  • Toribio, María Luisa
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
  • Bustelo, Xose R.
Rho guanine exchange factors (GEFs), the enzymes that stimulate Rho GTPases, are deemed as potential therapeutic targets owing to their protumorigenic functions. However, the understanding of the spectrum of their pathobiological roles in tumors is still very limited. We report here that the GEF Vav1 unexpectedly possesses tumor-suppressor functions in immature T cells. This function entails the noncatalytic nucleation of complexes between the ubiquitin ligase Cbl-b and the intracellular domain of Notch1 (ICN1) that favors ICN1 ubiquitinylation and degradation. Ablation of Vav1 promotes ICN1 signaling and the development of T cell acute lymphoblastic leukemia (T-ALL). The downregulation of Vav1 is essential for the pathogenesis of human T-ALL of the TLX+ clinical subtype, further underscoring the suppressor role of this pathway, X.R.B. is supported by grants from the Castilla-León Government (BIO/SA01/15, CSI049U16), Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2015-64556-R, RD12/0036/0002), Worldwide Cancer Research (14-1248), Ramón Areces Foundation, and Spanish Society Against Cancer. L.E. (PI13/00448), A.B. (SAF2013-40922-R, RD12/0036/0054), and M.L.T. (SAF2013-44857-R, RD12/0036/0075) are supported by MINECO grants. Spanish funding is partially supported by the European Regional Development Fund. We thank M. Blázquez for laboratory work, R. Valiente for ChIP-seq analyses, M. Dosil for comments on the manuscript, and CIC facilities' personnel for technical assistance
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Intracellular signals activated by canonical wnt ligands independent of GSK3 inhibition and β-catenin stabilization

  • García de Herreros, Antonio
  • Duñach, Mireia
In contrast to non-canonical ligands, canonical Wnts promote the stabilization of β-catenin, which is a prerequisite for formation of the TCF4/β-catenin transcriptional complex and activation of its target genes. This pathway is initiated by binding of Wnt ligands to the Frizzled/LRP5/6 receptor complex, and it increases the half-life of β-catenin by precluding the phosphorylation of β-catenin by GSK3 and its binding to the βTrCP1 ubiquitin ligase. Other intercellular signals are also activated by Wnt ligands that do not inhibit GSK3 and increase β-catenin protein but that either facilitate β-catenin transcriptional activity or stimulate other transcriptional factors that cooperate with it. In this review, we describe the layers of complexity of these signals and discuss their crosstalk with β-catenin in activation of transcriptional targets., This research was funded by grants from the Ministerio de Ciencia, Innovación y Universidades (RTI2018-099719-B-100 cofunded by Fondos Feder, SAF2013-40922-R1 and SAF2016-76461-R). Support from ICREA Academia is also appreciated.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence

  • Islam, Abul, 1978-
  • Guiu Sagarra, Jordi, 1983-
  • Bergen, Dylan J.M.
  • de Pater, Emma
  • Ayllon, Verónica
  • Gama-Norton, Leonor
  • Ruiz Herguido, Cristina
  • González, Jessica
  • López Bigas, Núria
  • Menéndez, Pablo
  • Dzierzak, Elaine
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cell (HSC) specification occurs in the embryonic aorta and requires Notch activation; however, most of the Notch-regulated elements controlling de novo HSC generation are still unknown. Here, we identify putative direct Notch targets in the aorta-gonad-mesonephros (AGM) embryonic tissue by chromatin precipitation using antibodies against the Notch partner RBPj. By ChIP-on-chip analysis of the precipitated DNA, we identified 701 promoter regions that were candidates to be regulated by Notch in the AGM. One of the most enriched regions corresponded to the Cdca7 gene, which was subsequently confirmed to recruit the RBPj factor but also Notch1 in AGM cells. We found that during embryonic hematopoietic development, expression of Cdca7 is restricted to the hematopoietic clusters of the aorta, and it is strongly up-regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation in a Notch-dependent manner. Down-regulation of Cdca7 mRNA in cultured AGM cells significantly induces hematopoietic differentiation and loss of the progenitor population. Finally, using loss-of-function experiments in zebrafish, we demonstrate that CDCA7 contributes to HSC emergence in vivo during embryonic development. Thus, our study identifies Cdca7 as an evolutionary conserved Notch target involved in HSC emergence., J. Guiu was a recipient of Formación Personal Investigador (FPI) BES-2008-005708. This research was funded by grants from the Ministerio de Economía y Competitividad, FEDER (SAF2007-60080, PLE2009-0111, SAF2010-15450, and SAF2013-40922R), Red Temática de Investigación Cooperativa en Cáncer (RTICC; RD06/0020/0098 and RD12/0036/0054), Association for International Cancer Research (AICR; 13-0064), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR; 2009SGR-23, CONES2010-0006) to A. Bigas, the Spanish Association against Cancer Research (AECC) to A. Bigas and P. Menendez, Fondo de Investigación Sanitaria (FIS; PI10/00449) to P. Menendez, and ZonMW TOP (40-00812-98-11068) to E. Dzierzak and E. De Pater.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A paradoxical tumor-suppressor role for the Rac1 exchange factor Vav1 in T cell acute lymphoblastic leukemia

  • Robles-Valero, Julio
  • Lorenzo-Martín, L. Francisco
  • Fernández-Pisonero, Isabel
  • Abad, Antonio
  • Camós, Mireia
  • Toribio, María Luisa
  • Espinosa, Lluis
  • Bigas, Anna
  • Bustelo, Xosé R.
Rho guanine exchange factors (GEFs), the enzymes that stimulate Rho GTPases, are deemed as potential therapeutic targets owing to their protumorigenic functions. However, the understanding of the spectrum of their pathobiological roles in tumors is still very limited. We report here that the GEF Vav1 unexpectedly possesses tumor-suppressor functions in immature T cells. This function entails the noncatalytic nucleation of complexes between the ubiquitin ligase Cbl-b and the intracellular domain of Notch1 (ICN1) that favors ICN1 ubiquitinylation and degradation. Ablation of Vav1 promotes ICN1 signaling and the development of T cell acute lymphoblastic leukemia (T-ALL). The downregulation of Vav1 is essential for the pathogenesis of human T-ALL of the TLX clinical subtype, further underscoring the suppressor role of this pathway., X.R.B. is supported by grants from the Castilla-León Government (BIO/SA01/15, CSI049U16), Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2015-64556-R, RD12/0036/0002), Worldwide Cancer Research (14-1248), Ramón Areces Foundation, and Spanish Society Against Cancer. L.E. (PI13/00448), A.B. (SAF2013-40922-R, RD12/0036/0054), and M.L.T. (SAF2013-44857-R, RD12/0036/0075) are supported by MINECO grants. Spanish funding is partially supported by the European Regional Development Fund. Open Access funded by Worldwide Cancer Research, Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Notch signal strength controls cell fate in the haemogenic endothelium.

  • Gama-Norton, Leonor
  • Ferrando Martorell, Eva, 1986-
  • Ruiz Herguido, Cristina
  • Liu, Zenhy
  • Guiu Sagarra, Jordi, 1983-
  • Islam, Abul, 1978-
  • Lee, Sung-Uk
  • Yan, Minhong
  • Guidos, Cynthia J.
  • López Bigas, Núria
  • Maeda, Takahiro
  • Espinosa Blay, Lluís
  • Kopan, Raphael
  • Bigas Salvans, Anna
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-mesonephros (AGM) region prior to haematopoietic stem cell (HSC) generation. The arterial programme depends on Dll4 and the haemogenic endothelium/HSC on Jag1-mediated Notch1 signalling. How Notch1 distinguishes and executes these different programmes in response to particular ligands is poorly understood. By using two Notch1 activation trap mouse models with different sensitivity, here we show that arterial endothelial cells and HSCs originate from distinct precursors, characterized by different Notch1 signal strengths. Microarray analysis on AGM subpopulations demonstrates that the Jag1 ligand stimulates low Notch strength, inhibits the endothelial programme and is permissive for HSC specification. In the absence of Jag1, endothelial cells experience high Dll4-induced Notch activity and select the endothelial programme, thus precluding HSC formation. Interference with the Dll4 signal by ligand-specific blocking antibodies is sufficient to inhibit the endothelial programme and favour specification of the haematopoietic lineage., L.G.-N. was a recipient of Marie Curie Intra-European Fellowship (PIEF-GA-2011- 302226). E.F. and J.G. are recipients of FPI (BES-2011-048360 and BES-2008-005708, respectively). This research was funded by the Ministerio de Economıa y Competitividad (PLE2009-0111, SAF2010-15450, SAF2013-40922-R), Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD12/0036/0054), Age`ncia de Gestio d’Ajuds Universitaris i de Recerca (AGAUR; 2014SGR-124) to A.B.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence

  • Islam, Abul, 1978-
  • Guiu Sagarra, Jordi, 1983-
  • Bergen, Dylan J.M.
  • de Pater, Emma
  • Ayllon, Verónica
  • Gama-Norton, Leonor
  • Ruiz Herguido, Cristina
  • González, Jessica
  • López Bigas, Núria
  • Menéndez, Pablo
  • Dzierzak, Elaine
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cell (HSC) specification occurs in the embryonic aorta and requires Notch activation; however, most of the Notch-regulated elements controlling de novo HSC generation are still unknown. Here, we identify putative direct Notch targets in the aorta-gonad-mesonephros (AGM) embryonic tissue by chromatin precipitation using antibodies against the Notch partner RBPj. By ChIP-on-chip analysis of the precipitated DNA, we identified 701 promoter regions that were candidates to be regulated by Notch in the AGM. One of the most enriched regions corresponded to the Cdca7 gene, which was subsequently confirmed to recruit the RBPj factor but also Notch1 in AGM cells. We found that during embryonic hematopoietic development, expression of Cdca7 is restricted to the hematopoietic clusters of the aorta, and it is strongly up-regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation in a Notch-dependent manner. Down-regulation of Cdca7 mRNA in cultured AGM cells significantly induces hematopoietic differentiation and loss of the progenitor population. Finally, using loss-of-function experiments in zebrafish, we demonstrate that CDCA7 contributes to HSC emergence in vivo during embryonic development. Thus, our study identifies Cdca7 as an evolutionary conserved Notch target involved in HSC emergence., J. Guiu was a recipient of Formación Personal Investigador (FPI) BES-2008-005708. This research was funded by grants from the Ministerio de Economía y Competitividad, FEDER (SAF2007-60080, PLE2009-0111, SAF2010-15450, and SAF2013-40922R), Red Temática de Investigación Cooperativa en Cáncer (RTICC; RD06/0020/0098 and RD12/0036/0054), Association for International Cancer Research (AICR; 13-0064), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR; 2009SGR-23, CONES2010-0006) to A. Bigas, the Spanish Association against Cancer Research (AECC) to A. Bigas and P. Menendez, Fondo de Investigación Sanitaria (FIS; PI10/00449) to P. Menendez, and ZonMW TOP (40-00812-98-11068) to E. Dzierzak and E. De Pater.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Lamin B1 mapping reveals the existence of dynamic and functional euchromatin lamin B1 domains

  • Pascual-Reguant, Laura, 1990-
  • Blanco, Enrique
  • Galan Martínez, Silvia, 1992-
  • Le Dily, François
  • Cuartero, Yasmina
  • Serra Bardenys, Gemma, 1992-
  • Di Carlo, Valerio
  • Iturbide Martínez de Albéniz, Ane, 1989-
  • Cebrià i Costa, Joan Pau, 1989-
  • Nonell Mazelon, Lara, 1972-
  • García de Herreros, Antonio
  • Di Croce, Luciano
  • Martí Renom, Marc A.
  • Peiró Sales, Sandra
Lamins (A/C and B) are major constituents of the nuclear lamina (NL). Structurally conserved lamina-associated domains (LADs) are formed by genomic regions that contact the NL. Lamins are also found in the nucleoplasm, with a yet unknown function. Here we map the genome-wide localization of lamin B1 in an euchromatin-enriched fraction of the mouse genome and follow its dynamics during the epithelial-to-mesenchymal transition (EMT). Lamin B1 associates with actively expressed and open euchromatin regions, forming dynamic euchromatin lamin B1-associated domains (eLADs) of about 0.3 Mb. Hi-C data link eLADs to the 3D organization of the mouse genome during EMT and correlate lamin B1 enrichment at topologically associating domain (TAD) borders with increased border strength. Having reduced levels of lamin B1 alters the EMT transcriptional signature and compromises the acquisition of mesenchymal traits. Thus, during EMT, the process of genome reorganization in mouse involves dynamic changes in eLADs, This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI15/00396; CPII14/0006), Ministerio de Economía y Competitividad (MINECO) (SAF2013-40922-R1; FPU14/0407; BFU2016-75008-P), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional-FEDER (SAF2016-76461-R), Generalitat de Catalunya (2014 SGR 32), Fundació FERO, Fundació La Marató TV3, and La Caixa Foundation. We also thank the Advanced Light Microscopy Unit at the CRG for their assistance and the Cellex Foundation for providing research facilities and equipment. M.A.M.-R. acknowledges funding from the European Research Council under the 7th Framework Program (FP7/2010-2015, ERC grant agreement 609989), the European Union’s Horizon 2020 research and innovation program (agreement 676556), the Spanish Ministry of Economy and Competitiveness (BFU2013-47736-P), and the Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208) to the CRG
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Intracellular signals activated by canonical wnt ligands independent of GSK3 inhibition and β-catenin stabilization

  • García de Herreros, Antonio
  • Duñach, Mireia
In contrast to non-canonical ligands, canonical Wnts promote the stabilization of β-catenin, which is a prerequisite for formation of the TCF4/β-catenin transcriptional complex and activation of its target genes. This pathway is initiated by binding of Wnt ligands to the Frizzled/LRP5/6 receptor complex, and it increases the half-life of β-catenin by precluding the phosphorylation of β-catenin by GSK3 and its binding to the βTrCP1 ubiquitin ligase. Other intercellular signals are also activated by Wnt ligands that do not inhibit GSK3 and increase β-catenin protein but that either facilitate β-catenin transcriptional activity or stimulate other transcriptional factors that cooperate with it. In this review, we describe the layers of complexity of these signals and discuss their crosstalk with β-catenin in activation of transcriptional targets., This research was funded by grants from the Ministerio de Ciencia, Innovación y Universidades (RTI2018-099719-B-100 cofunded by Fondos Feder, SAF2013-40922-R1 and SAF2016-76461-R). Support from ICREA Academia is also appreciated.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia

  • Robles-Valero, Javier
  • Lorenzo-Martín, L. Francisco
  • Menacho Márquez, Mauricio
  • Fernández-Pisonero, Isabel
  • Abad, Antonio
  • Camós, Mireia
  • Toribio, María Luisa
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
  • Bustelo, Xose R.
Rho guanine exchange factors (GEFs), the enzymes that stimulate Rho GTPases, are deemed as potential therapeutic targets owing to their protumorigenic functions. However, the understanding of the spectrum of their pathobiological roles in tumors is still very limited. We report here that the GEF Vav1 unexpectedly possesses tumor-suppressor functions in immature T cells. This function entails the noncatalytic nucleation of complexes between the ubiquitin ligase Cbl-b and the intracellular domain of Notch1 (ICN1) that favors ICN1 ubiquitinylation and degradation. Ablation of Vav1 promotes ICN1 signaling and the development of T cell acute lymphoblastic leukemia (T-ALL). The downregulation of Vav1 is essential for the pathogenesis of human T-ALL of the TLX+ clinical subtype, further underscoring the suppressor role of this pathway, X.R.B. is supported by grants from the Castilla-León Government (BIO/SA01/15, CSI049U16), Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2015-64556-R, RD12/0036/0002), Worldwide Cancer Research (14-1248), Ramón Areces Foundation, and Spanish Society Against Cancer. L.E. (PI13/00448), A.B. (SAF2013-40922-R, RD12/0036/0054), and M.L.T. (SAF2013-44857-R, RD12/0036/0075) are supported by MINECO grants. Spanish funding is partially supported by the European Regional Development Fund. We thank M. Blázquez for laboratory work, R. Valiente for ChIP-seq analyses, M. Dosil for comments on the manuscript, and CIC facilities' personnel for technical assistance
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia

  • Robles-Valero, Javier
  • Lorenzo-Martín, L. Francisco
  • Menacho-Márquez, Mauricio
  • Fernández-Pisonero, Isabel
  • Abad, Antonio
  • Camós, Mireia|||0000-0003-3658-7942
  • Toribio, María L.|||0000-0002-8637-0373
  • Espinosa, Lluis|||0000-0002-2897-4099
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Bustelo, Xosé R.
Rho guanine exchange factors (GEFs), the enzymes that stimulate Rho GTPases, are deemed as potential therapeutic targets owing to their protumorigenic functions. However, the understanding of the spectrum of their pathobiological roles in tumors is still very limited. We report here that the GEF Vav1 unexpectedly possesses tumor-suppressor functions in immature T cells. This function entails the noncatalytic nucleation of complexes between the ubiquitin ligase Cbl-b and the intracellular domain of Notch1 (ICN1) that favors ICN1 ubiquitinylation and degradation. Ablation of Vav1 promotes ICN1 signaling and the development of T cell acute lymphoblastic leukemia (T-ALL). The downregulation of Vav1 is essential for the pathogenesis of human T-ALL of the TLX + clinical subtype, further underscoring the suppressor role of this pathway. Robles-Valero et al. find that Vav1 facilitates binding of Cbl-b to the intracellular domain of Notch1 (ICN1) and promotes ICN1 degradation. Loss of Vav1 induces T cell acute lymphoblastic leukemia (T-ALL) by increasing ICN1 signaling, and TLX inhibits Vav1 expression to stimulate ICN1 signaling in TLX + T-ALL.